MedTrace Logo

The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%

NCT06030661 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1497

Last updated 2023-09-11

No results posted yet for this study

Summary

HF-POL is the first Polish multicenter observational prospective registry of patients with heart failure and ejection fraction more than 40% designed by Heart Failure Association of the Polish Cardiac Society. The purpose of this study was to provide first characteristics of Polish population patients with heart failure and EF\>40% and to provide a better understanding of medical practice, based on observational data, including diagnosis, treatment, and prognosis over 3-year follow-up.

Conditions

Sponsors & Collaborators

  • Medical University of Silesia

    collaborator OTHER

  • University of Opole

    collaborator OTHER

  • Medical University of Warsaw

    collaborator OTHER

  • Wroclaw Medical University

    collaborator OTHER

  • Military Institute od Medicine National Research Institute

    collaborator OTHER

  • Jagiellonian University

    collaborator OTHER

  • Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland

    collaborator OTHER

  • Medical University of Bialystok

    collaborator OTHER

  • Świętokrzyskie Cardiology Center of Kielce

    collaborator UNKNOWN

  • Regional Specialist Hospital in Rybnik

    collaborator UNKNOWN

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Malgorzata Lelonek, Prof.MD, PhD · Medical University of Lodz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-07
Primary Completion
2025-08-01
Completion
2025-09-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06030661 on ClinicalTrials.gov